-
Ingrezza Eases Tardive Dyskinesia Safely and Effectively Over Long-Term, Phase 3 Data Show
Read about long-term trials showing that treatment with Ingrezza provides stable amelioration of tardive dyskinesia with high patient satisfaction.
Click here to know more about it.
What are your thoughts on this news?
Sorry, there were no replies found.
Log in to reply.